Expert speakers
Experienced learnings shared directly by leaders shaping the industry.
8th Annual
Pharma Manufacturing
Pharma Manufacturing
& Automation
Convention 2026
Beyond Automation: Building Faster, Smarter & More Adaptive Pharma Enterprises.
Co-located with
Pharma Manufacturing & Automation Excellence Awards 2026
Days left to go
00
Days
00
Hours
00
Minutes
00
Seconds
About the event
India’s premier pharma manufacturing convention.
For years, the pharmaceutical industry has invested heavily in automation, digitisation and smart manufacturing. Yet many familiar challenges remain, from production delays and technology transfer gaps to disconnected functions, rising costs, workforce shortages and implementation failures. The question, therefore, is no longer simply what technology should come next, but how organisations can make better decisions and turn these investments into meaningful business performance.
Built around the theme “Beyond Automation: Building Faster, Smarter & More Adaptive Pharma Enterprises,” the 8th Annual Pharma Manufacturing & Automation Convention 2026, taking place on October 27th - 28th at Novotel Hyderabad Airport, will bring together industry leaders to explore the thinking, leadership and collaboration required for the next phase of manufacturing excellence. Across two days, the conversation will examine stronger decision-making, smarter production planning, effective technology transfer, practical AI adoption, workforce capability and cross-functional collaboration.
350+
Delegates
30+
Expert speakers
8th
Annual edition
2
Focused days
Why attend
Make the next move, with the right people in the room.
A purpose-built environment for knowledge exchange, collaboration and commercial opportunity across pharma manufacturing.
Interactive Q&A
Genuine two-way conversation, not a one-way lecture.
Real-world case studies
Practical group discussions grounded in real plant-floor problems.
Networking reception
Structured business opportunities beyond the sessions themselves.
Future insights
Advanced technology demos previewing what's coming next.
6-month support
Guaranteed follow-up support for questions after the event ends.
Who can attend?
From CxOs, Managing Directors, Presidents, and Vice Presidents to Sr. GMs, GMs and mid-level management members, everyone can reap the benefits of this platform to learn and network with industry peers.
CxOs
Managing Directors
Presidents
Vice Presidents
Sr. GMs & GMs
Mid-level Management
Speakers of 2026
Industry leaders shaping pharma's next chapter.
Speakers across manufacturing, quality, automation and digital transformation.
Prashant Sharma is the Chief Technical Officer at Zydus Group. An MBA professional with a first-class bachelor’s degree in Electronics Engineering, he brings over three decades of diverse industry experience. He strongly believes in learning agility and that formative experiences across different verticals shape better leaders. His wide-ranging roles, spanning global demand and supply chain, procurement and warehousing, human resources, corporate communications and operations, manufacturing, and technology in both MNCs and leading Indian organisations, stand as a testament to this belief.
At the foundation of his journey lies a keen desire to keep learning and challenging himself, taking risks, and building teams that consistently perform beyond expectations.
Beyond his professional accomplishments, Prashant is deeply passionate about animal welfare. He works closely with NGOs dedicated to the cause and has three rescued cats at home. He is equally committed to environmental causes, enjoys reading, and actively promotes awareness in the area of financial planning. He feels that many professionals fail to prepare adequately for their retirement years and advocates for financial literacy as an essential life skill.
Mr. Abhay, a seasoned leader with a remarkable blend of academic and professional accomplishments. Mr. Abhay holds a Master's degree in Business Administration and is also a pharmacy graduate. Additionally, he is a Certified Six Sigma Black Belt and an Executive alumnus of the prestigious Indian Institute of Management, Lucknow.
Mr. Abhay has held various leadership roles at renowned organizations such as USV, ALKEM, and Sun Pharma. Currently, he serves at Mankind Pharma, where he is responsible for driving the overall manufacturing strategy and transformation across Operations, Projects, Engineering, Environmental Health and Safety (EHS), and Operational Excellence for Mankind's Pharma, Agritech, and Pet Food businesses.
Under his leadership, Mankind Pharma has significantly elevated its manufacturing capabilities in Formulations, API, Pet Food, and Agritech plants. As a forward-thinking leader, Mr. Abhay is dedicated to creating agility in Mankind's operations by undertaking disruptive process transformations and embracing digital transformation across all aspects of the supply chain.
Tushar Zade is the Chief Transformation Officer at Granules India, where he is responsible for driving enterprise transformation by combining business strategy, Artificial Intelligence, Digital, Data, Operational Excellence, and Innovation to build future-ready businesses.
A Computer Science Engineer and an IIM Ahmedabad alumnus, Tushar brings over 17 years of leadership experience spanning entrepreneurship, pharmaceuticals, business transformation, and AI-led innovation. Throughout his career, he has remained passionate about one thing above all else—building businesses that create long-term value.
He believes every successful business evolves through distinct phases—0→1, 1→10, 10→100, and beyond. While the tools and technologies evolve, the principles remain timeless: identify meaningful problems, build differentiated capabilities, earn customer trust, scale sustainably, and continuously reinvent for the future.
Before entering the pharmaceutical industry, Tushar co-founded and successfully scaled a technology startup, delivering 10X business growth before achieving a successful exit. The entrepreneurial journey instilled in him a deep appreciation for customer obsession, speed of execution, commercial thinking, and building organizations from first principles.
Prior to Granules India, Tushar spent over 11 years with Dr. Reddy's Laboratories and Aurigene Pharmaceutical Services, where he held leadership positions across IT, Digital Transformation, Scientific Informatics, Commercial Excellence, and Artificial Intelligence.
One of his most significant achievements was envisioning and building Aurigene.ai—an AI-powered drug discovery platform that grew from a bold idea into a globally recognized business capability. Beyond developing technology, he built an ecosystem around it by strengthening customer trust through enterprise-grade AI governance, data privacy, SOC-compliant security, and responsible AI practices, helping establish Aurigene.ai as a differentiated brand in the global life sciences ecosystem.
Across his career, Tushar has consistently transformed technology from a support function into a strategic growth engine, leading initiatives across AI, Digital Manufacturing, Scientific Platforms, Commercial Excellence, Data Platforms, Cybersecurity, and Enterprise Transformation. His work has always focused on one outcome: creating measurable business value through scalable capabilities and high-performing teams.
A recognized global thought leader, Tushar is a sought-after keynote speaker and panelist on AI, Pharma 4.0, Digital Manufacturing, Business Transformation, and the Future of Work. His perspectives on AI-driven enterprises, digital supply chains, intelligent drug discovery, and organizational transformation have been featured at leading global industry forums.
His contributions have earned numerous national and international recognitions, including being a four-time CIO100 Award winner, Digital Infrastructure Master, Progressive CIO, Global Choice Award – CDO of the Year, Innovative CIO, Trendsetter CIO, Business Mint 40 Under 40, Most Prominent Digital Transformation Leader, and the Indian Achievers' Award, among several other industry accolades.
Beyond the boardroom, Tushar is an accomplished musician, former radio jockey, guitarist, vocalist, and passionate Dhol artist. He believes music has been one of his greatest leadership classrooms, teaching him resilience, collaboration, discipline, and the importance of listening before leading.
Mr. Vipul Doshi is a pioneering leader in the Indian pharmaceutical industry, with over four decades of distinguished experience encompassing diverse leadership and operational domains. Renowned as a key architect in the pharmaceutical sector, he has built an illustrious career across multiple businesses and functions within leading pharmaceutical organizations.
Over the years, Mr. Doshi has led critical functions including Drug Discovery, Generic Research, Quality, Regulatory Affairs, Pharmacovigilance, and several other strategic areas, demonstrating exceptional leadership and domain expertise. His contributions have been instrumental in strengthening organizational capabilities and driving excellence across these functions.
He has been a significant contributor to the development and implementation of robust quality systems and a culture of excellence grounded in core values and ethical practices. His leadership has enabled organizations to enhance operational efficiency, integrate quality mindsets, and strengthen overall regulatory compliance.
Mr. Doshi has also been a strong advocate for global competitiveness and has played a pivotal role in due diligence related to various mergers and acquisitions. His expertise extends to projects and engineering, particularly in developing world-class infrastructure for Active Pharmaceutical Ingredients (APIs) and drug products, including both sterile and non-sterile dosage forms.
He has been actively associated with several prestigious professional associations, including ISPE, PDA, and AAM, contributing to knowledge sharing and industry advancement. With a career marked by progressive responsibilities, Mr. Doshi currently serves as the Chief Quality & Compliance Officer at Zydus Lifesciences Limited.
A seasoned business leader with over two decades of experience across Pharmaceuticals, Medical Devices, Telecom, Banking, and Insurance. Has held leadership roles with organizations including Agnus Capital, Mylan, Aspen Pharmacare, Skanray Devices, Vodafone, ICICI Bank, and TATA AIG, delivering strategic initiatives across Latin America, Europe, Africa, and Southeast Asia. Holds an MBA from the University of Mysore and has completed the Advanced Management Program from IIM Bangalore.
Dr. Manoranjan Kumar is an accomplished pharmaceutical quality professional with over 32 years of experience in the industry. He holds an M.Sc. and Ph.D. in Analytical Chemistry and has completed an Executive Management Course from Narsee Monjee Institute of Management Studies (NMIMS), Mumbai. Over the course of his career, he has been associated with leading pharmaceutical organizations including Lupin, E-Merck, Unichem, Fresenius Kabi, and Mylan. Currently, he serves as Senior Vice President and Head of Corporate Quality Assurance, where he is responsible for overseeing the overall Quality function across Hetero API and its subsidiary sites. His key areas of expertise include Quality Control (QC), Quality Assurance (QA), Development Quality Assurance (DQA), and Analytical Development across both formulations and APIs.
An alumnus of GE's Operating Managers Leadership Program and Kellogg's Advanced Global Management Program, Kulbhushan has handled various Business transformation and Re-engineering initiatives at Global level. With over three and a half decades of Innovative Global Working Experience in strategic planning, operations strategy & excellence, digital transformation, and supply chain re-engineering, Kulbhushan has led transformation in Multi product & multiple sites environment.
In his current role at Dr Reddy's Laboratories, he is leading global operations strategy and excellence handling 14 manufacturing locations across India and North America regions. He has done various leadership roles in companies like GE, Sun pharma and jubilant group in the past.
He is an avid traveler, always explore local culture during his travels and has deep fondness for colors, art, painting and music.
Ciaran O’Keeffe is the Regional Sales Director for MasterControl’s Asia Pacific Headquarters in Singapore, where he has spent over seven years helping life sciences organizations accelerate their digital transformation. In this role, he has partnered with more than 100 biopharmaceutical and medical device companies to successfully implement MasterControl’s industry-leading Quality and Manufacturing solutions. Ciaran has been responsible for several of the largest and most complex implementations of digital quality and manufacturing solutions at Asia Pacific-based life science manufacturers.
With over a decade of experience delivering enterprise software across highly regulated industries in the Asia Pacific region, Ciaran brings a combination of commercial insight and hands-on implementation expertise. His approach helps organizations identify the right technology, and also ensure its seamless adoption to drive measurable business impact.
Ciaran holds a Bachelor’s Degree in International Commerce and Chinese Language from University College Dublin, Ireland, and is passionate about bridging innovation with operational excellence in the life sciences sector.
Rajendra Chunodkar has recently retired as President Manufacturing Operations from Lupin Ltd. He was heading all Manufacturing sites in India and was also responsible for Corporate Projects and Engineering Services, Global Operational Excellence, Corporate EHS, Formulation Tech Transfer, Process Development Laboratories for API and Formulations. He joined Lupin in 1986 and in his three decades with Lupin, he has handled various roles including Global Supply Chain, Technology Transfer, Manufacturing, Projects, etc.
He has done Bachelor of Chemical Engineering from Institute of Chemical Technology, Mumbai, Diploma in Systems Management from Jamanalal Bajaj Institute of Management Studies, Mumbai University in 1985, and PGPMAX from Indian School of Business (ISB), Hyderabad in 2014.
Achievement-Driven Professional with cross functional experience in diverse functions and equipped with over 33 years of proficiency in the pharmaceutical industry. Strength in leading large teams across the globe, planning, executing & spearheading all the functions right from research, manufacturing of APIs and Formulations, Quality, business development to Sales and marketing functions with a P & L responsibility. Served at operational and leadership positions at MSD, Pfizer Ranbaxy, Dabur, Gland, Lupin, Eisai etc. He pursued M.Pharm, PhD from Punjab University Chandigarh.
He is the Ex MD of Eisai a Japanese pharma company. Currently he is associated with Biocuris pharmaceuticals, Founder and CEO at Chandigarh.
Awarded thrice in the list of one of the “100 of the Most Inspiring People” in the life science industry by PharmaVOICE, USA. Associated with professional bodies like Indian Pharmaceutical Association, International Society for Pharmaceutical Engineers (ISPE) and serves as Past Chair – India Chapter for Parental Drug Association (PDA) and past Chairman - Technical & Supply Chain committee for Organization of Pharmaceutical Producers of India (OPPI). With a patient-first mentality and a philosophy that quality is everyone’s responsibility, continue to lead to further advance operational excellence and quality culture across the industry.
Mr. A V Jayakumar is a senior quality professional with over 30 years of experience in the pharmaceutical industry. He is well known in the pharmaceutical circle for his accomplishments.
He completed his master's in analytical chemistry from Sardar Patel University, V V Nagar, Anand, Gujarat in 1994.
He started his career as a quality control analyst with Torrent Pharma and was subsequently associated with Cipla, Aurobindo, USV, and Glenmark in various mid-management and leadership roles. At present, he is responsible for the global quality operations of Ajanta Pharma Ltd. Ajanta has seven state-of-the-art manufacturing sites spread across different geographies of India.
When he started taking up leadership roles, he acquired the skill of handling regulatory requirements and stringent regulatory inspections.
He is an expert in evolving sites from scratch to meet all SRA compliance requirements. He is also skilled at delivering training and has conducted several audits in India and overseas.
He has participated in several seminars, webinars, and panel discussions, delivering his thoughts on various topics contributing to the pharma industry’s knowledge upgrade.
He has executed several digital transformation programs at his current organisation, making laboratory and manufacturing operations paperless and meeting Industry 4.0 requirements.
During his career, he dealt with all stringent regulatory authorities during inspections, preparing responses and their ongoing compliance program.
Rajesh T is Digital & Business Process Excellence at Dr. Reddy’s Laboratories, with over 25 years of experience across manufacturing, quality and digital transformation, including 18 years with Dr. Reddy’s.
He has been at the forefront of transforming a large, brownfield generic-pharma manufacturing network, from paperless execution and Industry 4.0 adoption to Lighthouse-class performance and the emerging era of AI-led intelligent manufacturing. His work focuses on making digital transformation accountable for tangible business outcomes, including cost of poor quality, working capital, release cycle time, yield and throughput.
Rajesh’s approach to transformation is built around four principles: strategy before technology, simplification before automation, enterprise-scale execution over isolated pilots, and capability building as the multiplier for sustainable change. He believes that AI creates meaningful value only when it is built on simplified, well-owned processes rather than used to automate existing complexity.
Under his digital leadership, the organization has developed 60+ business-linked Industry 4.0 use cases spanning much of the digital manufacturing landscape, enabled exception-based and AI-assisted manufacturing release at scale, and advanced the quality function from reactive control toward predictive foresight across 18 global sites and a 90+ member team.
His work has also contributed to the digital transformation journey behind a flagship site’s recognition in the World Economic Forum Global Lighthouse Network.
Beyond his organizational responsibilities, Rajesh contributes to the wider pharmaceutical and manufacturing community through his involvement with ISPE GAMP good-practice guides on data integrity, authored chapters on cleanroom and aseptic validation, and speaking engagements at national and international forums on AI-enabled quality, Industry 4.0 and digital manufacturing.
Rajesh is passionate about helping organizations move beyond digital pilots to build intelligent enterprises where technology, processes, people and business outcomes work together to create sustained operational value.
Jenil Dedhia leads business and partnerships at Leucine, bringing AI into the heart of quality and manufacturing operations. He drives adoption of an AI-native platform that unifies MES, QMS, Validation, and LIMS on a single data model, with AI agents that detect deviations as they happen, support investigations, and help teams work by exception rather than by paper. His focus is helping manufacturers move from digitised records to intelligent, audit-ready operations, with end-to-end compliance built in.
Shivkumar Iyer is a senior API pharmaceutical professional with over 35 years of experience spanning API manufacturing, technology transfer, process engineering, project management, plant commissioning, operational excellence and manufacturing operations. He currently serves as Senior Director – API Technology Transfer at Cipla Pharmaceuticals Ltd., where he heads Kilo Lab, Pilot Plant, Process Engineering and multi-location API technology transfer. His expertise covers the complete API manufacturing lifecycle, including process scale-up, technology transfer, process robustness, QbD, process safety, capacity enhancement, cost optimisation and Right First Time (RFT) execution. He is also focused on the evolving role of digitalisation, data analytics, process automation and technology-enabled decision making in strengthening manufacturing performance, process control and operational excellence.
Throughout his career with Cipla, Teva, Dr. Reddy’s, Orchid, Gujarat Themis Biosyn, Lupin and Standard Organics, Shivkumar has led major technology-transfer, manufacturing, commissioning and operational initiatives. He has been involved in the execution and transfer of 250+ products, and developed strong capabilities in cross-functional leadership, project management, team development and customer/regulatory engagement. His professional interests increasingly encompass digital transformation of API manufacturing, manufacturing analytics, data-driven process optimisation, automation, AI-enabled decision support and the integration of science, technology and operational excellence. He has also been a speaker, panelist and chairperson at pharmaceutical conferences and industry forums, sharing his perspectives on technology transfer, AI in pharma, regulatory practices, manufacturing and automation.
Sandeep Majumdar is a senior biopharmaceutical operations leader with nearly three decades of experience in biologics and biosimilars manufacturing, process development and large-scale biopharmaceutical projects. His expertise spans upstream and downstream processing, manufacturing operations, technology transfer, plant design, automation, PAT, QbD, process intensification and digital transformation. He has held senior leadership positions at Intas Pharmaceuticals, Biocon and Reliance Life Sciences and has contributed to the development and commercialization of complex biologics and biosimilars. Now he is leading Biologics operations for Zydus Life Sciences as EVP. He is particularly focused on improving manufacturing productivity, reducing COGS, enhancing quality and reliability, and deploying advanced technologies for future-ready biopharmaceutical manufacturing. He has led various projects for MES implementation across various complex manufacturing. He has proven leadership in sterile operations in Biologics. He has led Intas as the person most responsible for USFDA approval for multiple Biologics.
Mr. Atul Shastri brings over 38 years of extensive experience in the pharmaceutical industry, with a proven track record in manufacturing, operations, and engineering projects. He is the President of Operations at Eugia Pharma Specialities and has held leadership roles across several renowned companies, including Aurobindo Pharma, Intas Pharmaceuticals, Zydus Group, and Ranbaxy. He has demonstrated exceptional capabilities in overseeing manufacturing operations, driving efficiency, and leading large-scale projects, particularly in setting up and managing plants.
With expertise in GMP, Technology Transfer, Validation, and Regulatory Affairs, Atul has been instrumental in developing and implementing robust quality systems and compliance protocols. His strategic approach and deep understanding of operations have played a crucial role in shaping the success of various manufacturing facilities, ensuring consistent quality and timely delivery of products. His leadership continues to drive operational excellence across global teams.
Mr. Rahul Gaur is an accomplished IT and Digital Transformation professional with over 22 years of experience in IT infrastructure, operations, digitization, governance, risk and compliance, service delivery, and IT SOX compliance.
He holds a Bachelor of Commerce from Delhi University and an MBA in IT & Finance, along with ITIL v3 and COBIT 5 certifications. At Eugia Pharma Specialities Limited, he leads IT operations and digital transformation initiatives across Indian and global locations.
Having previously worked with organizations such as Pfizer, Hospira, Coca-Cola, and Dabur, he brings extensive experience in managing complex technology programs and diverse teams. His key strengths include leadership, stakeholder management, IT governance, regulatory compliance, and delivering business-focused digital initiatives.
Dr. Deepak Haldankar brings over 40 years of leadership experience in the pharmaceutical industry, having led manufacturing, quality, technology, and business transformation across leading pharmaceutical organizations in India. His career includes executive roles as Chief Technology Officer (CTO), Chief Operating Officer (COO), President (Technical), and Vice President – Corporate Quality, with a strong track record in operational excellence, regulatory compliance, and sustainable business growth.
His expertise spans the pharmaceutical value chain, including API, formulations, manufacturing operations, corporate quality, technology transfer, regulatory compliance, operational excellence, greenfield and brownfield projects, and strategic leadership. He has extensive experience across tablets, capsules including hard gelatin and softgel, injectables, dry syrups, oral liquids, ointments, gels, aerosols, oncology products, and other dosage forms.
Over the course of his career, Dr. Haldankar has successfully led and supported more than 70 international regulatory inspections conducted by agencies including the US FDA, MHRA (UK), TGA (Australia), PMDA (Japan), WHO, ANVISA (Brazil), MCC (South Africa), PIC/S authorities, INVIMA, and European regulators, while consistently maintaining high standards of compliance and inspection readiness.
He has remained focused on building high-performing organizations, strengthening quality culture, improving manufacturing productivity, optimizing costs, accelerating technology transfer, and driving continuous improvement. His leadership philosophy is rooted in the belief that sustainable success comes from combining operational discipline, innovation, and strong leadership.
Having travelled to more than 40 countries, he has represented organizations at international conferences, regulatory forums, customer meetings, and industry events including PITTCON (USA), CPHI, JAIMA (Japan), and IPC (India), while developing strategic partnerships across the global pharmaceutical industry.
Currently serving as Executive Advisor at Nepra Pharmaceuticals, Dr. Haldankar advises pharmaceutical organizations on manufacturing excellence, regulatory readiness, quality systems, technology transfer, operational transformation, due diligence, and growth strategy. He also supports leadership teams, promoters, investors, and CDMOs in building world-class pharmaceutical organizations.
Rakesh Kumar Sinha is a seasoned pharmaceutical manufacturing leader with over 32 years of experience across pharma, vaccines, and biosimilar manufacturing. Throughout his career, he has provided strategic direction and operational leadership for large-scale and multi-site manufacturing operations, with a strong focus on quality, productivity, compliance, and organizational excellence.
He has led significant transformations in manufacturing and quality culture through the implementation of Total Quality Management (TQM), Total Productive Maintenance (TPM), digitization, and automation, helping organizations improve process efficiency while strengthening cost competitiveness. He also brings extensive experience in FDA-regulated environments and has led remediation efforts related to FDA Official Action Indicated (OAI) observations in collaboration with third-party consultants.
Beyond operational excellence, Rakesh places strong emphasis on talent development, coaching, leadership capability, and building high-performing organizational cultures. Environmental, Health and Safety (EHS) remains central to his leadership philosophy, alongside a continued commitment to responsible and sustainable manufacturing.
His leadership was particularly demonstrated during the COVID-19 pandemic while serving as Site Head at Dr. Reddy’s Baddi plant in Himachal Pradesh. Amid rapidly evolving circumstances and changing regulatory requirements, he ensured continuity of manufacturing and optimal production of life-saving medicines while prioritizing the health, safety, and welfare of employees. He also successfully mobilized and motivated the workforce across three adjoining states to maintain critical operations during one of the most challenging periods for the pharmaceutical industry.
Satish H. Agrawal holds a Master of Pharmacy and a Bachelor of Pharmacy, both from the University of Pune, Maharashtra.
He currently serves as President (Technical & Operations) at Ajanta Pharma Ltd., a pharmaceutical company headquartered in Mumbai. He is a highly motivated and result-oriented professional with around 34 years of experience in Pharmaceutical formulations, Production, Procurement, Project management and Information Technology. He has travelled the path from Production Pharmacist to President (Technical and Operations).
He is actively involved in various social organizations such as the Indian Pharmaceutical Association, Samta Foundation (working for women empowerment, health & children education), and Akhil Bhartiya Agrawal Sammelan (welfare of the community).
His awards and recognitions include the Ajanta Pharma Chairman's Star Performance Award (2008), the Economic Times Pharma Leader Award (2021), a Certificate of Appreciation as a Corona Warrior from the Hon'ble Governor of Maharashtra for service rendered during the lockdown against Covid-19, and the Apex India Visionary Leader Award (2023).
He has led key initiatives in automation and digitization, including digital transformation across manufacturing sites to create a fully digitalized, paperless factory through implementation of L2 Integration via PAS-X (MES), E-LIMS, E-Log for equipment, SAP ERP, Warehouse Management System (WMS), Ecubix, and real-time dashboards. He has also driven fully automatic manufacturing & packing lines equipped with the best and latest equipment and software to reduce manual intervention and increase efficiency, and sustainability initiatives including 33% solar energy utilization and a 41% reduction in annual carbon emissions. This digital transformation has earned the company several awards, including National Kaizen Awards (CII) across 10 categories, Poka-Yoke Awards (CII), a Supply Chain Excellence Award, and a Best Facility Award. He has also built an Operational Excellence team using existing employees, driving Lean, Kaizen, and TPM internally.
Event Partners
The organisations supporting PMAC 2026 across every level of partnership.
Panel Discussion Partner
Pivot Path
Pivot Path is a life sciences solutioning organization that integrates technology, platforms and pharma domain expertise to deliver transformative outcomes for customers across the globe. With a team of over 500 pharma experts, we serve 60+ clients across five continents, covering the entire life sciences value chain. Our capabilities span a comprehensive range of services, including global pharmacovigilance, clinical operations, intellectual property rights, quality and digital compliance, IT and people & digital services — enabling organizations to accelerate innovation and drive sustainable, meaningful growth.
Learn more
Cocktail Partner
ComplianceQuest
ComplianceQuest is the #1 AI-powered Quality, Risk, and Compliance (QRC) platform that connects Product, Quality, Manufacturing, People, Suppliers and Customers in a single system. Built on Salesforce, the platform delivers end-to-end visibility, AI-driven intelligence, and enterprise-scale execution, enabling organizations to manage risk, ensure regulatory compliance, and turn quality into a driver of growth.
Learn more
Gold Partner
MasterControl
MasterControl Solutions Inc. is a leading provider of cloud-based quality and compliance software for life sciences and other regulated industries. Our mission is the same as that of our customers – to bring life-changing products to more people sooner. The MasterControl Platform helps organizations digitize, automate and, connect quality, and compliance processes across the regulated product development life cycle. The MasterControl Manufacturing Excellence™ solution, used by over 150 organizations globally, is a highly configurable and quick-to-implement Modern Manufacturing Execution System (MES), helping life sciences manufacturers bridge the paper gap between quality management systems (QMS) and the production floor by automating the labor-intensive last mile of the manufacturing production process to drive immediate improvement and operational efficiency. Over 1,000 companies worldwide rely on MasterControl solutions to achieve new levels of operational excellence across product development, clinical trials, regulatory affairs, quality management, supply chain, manufacturing, and postmarket surveillance.
Learn more
ABB
ABB is a global technology leader in electrification and automation. We see our purpose as being to enable a more sustainable and resource efficient future. By connecting our engineering and digitalization expertise, we help industries run at high performance, while becoming more efficient, productive, and sustainable so they outperform. We call this: ‘Engineered to Outrun.’ We have around 110,000 employees worldwide and a history that stretches back more than 140 years. Since its inception in 1949, ABB India has facilitated nation’s automation, digitalization, and electrification. Our technology is seamlessly entrenched in the fabric of Indian life.
Learn more
Silver Partner
Leucine
Leucine believes the future of pharma is intelligent. The company was founded by Vivek Gera after seeing an industry drowning in paper: batch records printed and reprinted, deviations logged by hand, quality reviews that took weeks instead of minutes. Headquartered in New York, Leucine built the AI-native platform for pharmaceutical manufacturing from the ground up, with intelligence as the foundation rather than a feature added later. Its products span the full GMP lifecycle: an AI-powered MES, an AI-QMS, CLEEN for cleaning validation, Celestara as the AI Quality Nerve Center, and FDA Tracker for regulatory intelligence on 14,000+ FDA enforcement records. Compliance is designed in, not bolted on, so the platform handles the burden of proof while teams focus on making medicine. Today Leucine runs in production at 400+ GMP facilities across 10+ regulatory jurisdictions, with a 100% go-live record and some of the world's most heavily inspected manufacturers, including a WEF Global Lighthouse site, on the platform. Built by people who visit plants, read SOPs, and sit through audits, Leucine turns compliance from a burden into a competitive advantage.
Learn more
Techsol Life Sciences
Techsol Life Sciences is an integrated clinical development, medical affairs and post-marketing surveillance business solutions provider to global biopharmaceutical,
medical device, food, and nutraceuticals companies. With our commitment to bringing novel treatments and therapies faster to market, we deliver regulatory compliant
clinical research services, GxP technology consulting solutions in combination with our unified SaaS platforms.
Using our deep-domain scientific expertise and technology innovation, we help sponsors to reduce time-to-market, save costs, and realize maximum value, across pharmaceutical
and medical device business functions through clinical research, compliance oversight, insights generation, digitalization and GxP process automation.
Thermo Fisher Scientific
Thermo Fisher Scientific: Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $35 billion.
Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,
solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them.
Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through
our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.
Digital Science Solutions: Thermo Fisher Scientific has industry leading scientific, and laboratory operational excellence paired with an extensive portfolio of digital
capabilities to aid in your journey of digital transformation. Digital Science Solutions delivers market-leading laboratory and data management solutions in the form of
our available LIMS, ELN, and SDMS software and industry-vertical software solutions.
Exclusive Networking Partner
Veeva
Veeva Systems – Transforming Pharma through Cloud-Based Automation and Innovation Veeva Systems is a global leader in cloud-based software solutions for the life sciences industry. With a mission to help companies bring medicines and therapies to patients faster and more efficiently, Veeva delivers a comprehensive suite of solutions that spans the full product lifecycle—from research and development to commercialization. Our industry-specific solutions are designed to meet the unique regulatory, quality, and compliance needs of pharmaceutical, biotech, and medical device companies. Veeva’s flagship applications, including Veeva Vault—the only cloud-based platform tailored for regulated industries—enable organizations to unify content and data management, streamline processes, and drive automation across the enterprise. With deep expertise in the domains of quality, regulatory, safety, clinical, commercial and medical affairs, Veeva is trusted by more than 1,500+ companies globally, including emerging biotech’s and the world’s largest pharmaceutical enterprises. Our suite of Quality applications, including Veeva QMS, Veeva QualityDocs, Veeva Training, Veeva Batch Release, Veeva Validation Management, Veeva LIMS, Veeva Station Manager and Learn GxP is transforming the way life sciences companies manage quality processes, improving compliance, efficiency, and innovation. Veeva AI is agentic AI in the Vault Platform and industry-specific application agents in all Veeva applications. Veeva Falcon automates end-to-end business processes with an agentic workforce of standard agents. Veeva’s commitment to customer success drives us to continuously innovate. Our cloud platform’s scalability, built-in compliance, and industry best practices help companies adapt to regulatory changes, reduce operational risks, and accelerate time to market. Headquartered in Pleasanton, California, with offices around the world, Veeva Systems is dedicated to advancing the life sciences industry through automation, innovation, and collaboration.
Learn more
Exhibit Partner
Anmeda Systems
Anmeda Systems provides innovative solutions to pharma and biotech companies. Bringing an innovative combination of hardware and software, Anmeda provides compelling solutions in pharma production, manufacturing and quality that help companies leverage existing infrastructure to achieve complete regulatory compliance, data security and integrity. With real-time analytical solutions, companies get insight into their processes, boosting performance and quality with actionable information. Anmeda is a trusted partner of large pharma companies such as Aurobindo, Amneal and others.
Learn more
ValGenesis
ValGenesis delivers the industry's leading AI-enabled digital platform for process design, CQV, and ongoing verification across the life sciences. Through the Smart GxP™ platform, organizations execute GxP workflows with built-in compliance and real-time insights — ensuring quality, reducing risk, and accelerating the delivery of high-quality products to market.
Learn moreMedia Partners
Organisations who've previously partnered with PMAC
Past Partners
Why partner
Be seen by the people moving the industry forward.
PMAC creates a considered environment for partners to build direct relationships with pharma leaders and decision makers.
To protect value for every partner, the number of companies in each product or service category is strictly limited.
250+ decision makers
Meaningful face-time with CxOs, VPs and senior manufacturing leaders.
Focused networking
Structured opportunities to turn introductions into conversations.
Category exclusivity
A limited number of vendors per category protects your visibility.
Extended reach
Event visibility across media, digital channels and post-event support.
What people say
Told by the people who were in the room.
Registration
Choose how you attend PMAC 2026.
Two straightforward options — pick the one that fits how your organisation wants to be represented.
₹50,000
+ GST
- Full 2-day conference access
- Access to all keynote and panel sessions
- Networking reception entry
- Delegate kit and event materials
*These prices are applicable for pharmaceutical companies only.
Moments from past editions
Join us at Novotel Hyderabad Airport.
October 27th - 28th, 2026— here's everything you need to plan your visit.
Event Venue
Novotel Hyderabad Airport
R. Gandhi International Airport, Shamshabad, Hyderabad, Mamidpally, Telangana 500108
-
Event Dates October 27th - 28th, 2026
-
Call Us +91 9653 284 123
-
Email Us marketing@eminencemedia.in